October 2020

Cancer affects nearly each and every part of our body.

There exist over two hundred different types of cancers. Cells in our bodies normally grow, divide, and produce more cells to perform specials tasks.

When these normal healthy cells grow old or get damaged they die and are replaced by new cells to perform the same duties.

The names of many types of cancers are often associated with the organs it affects.

Information on cancer can be obtained from various Health Information Centers and help one in detecting the initial signs of the disease.

Researchers and scientists have classified common types of cancer into five broad categories:

(1) Central Nervous System Cancers – The brain and the tissues of the spinal cord are primarily affected.

(2) Carcinoma – related cancers originate in the skin, and also in tissues that cover organs residing inside the body. The other parts affected by this type of cancer are the stomach, liver, breast, prostate, and the colon.

(3) Leukemia – begins in the bone marrow (and other tissues where blood is formed), causing the formation of abnormal blood cells that enter the bloodstream.

(4) Sarcoma – cancer that starts from connective or supportive tissue cells. Examples include blood vessels, muscle, fat, bone, and cartilage.

(5) Myeloma and Lymphoma – develop in the cells located in the immune system.

Besides these common types of cancers, it is a fact that cancer can be caused due to infections.

The list of risk factors is vast and varied including age, gene inheritance, hormones, obesity, specific viruses and bacteria, unhealthy eating habits, alcohol, artificial substances, sunlight, chemicals, radiation.

One should not be surprised to see age among the list of common cancer risk factors. Aging is a natural process no one can avoid but leading a healthy lifestyle helps avoid cancer.

Statistics show that the majority of cancer patients are comprised of senior citizens and they suffer mainly from common types of cancers.

As a result, they are not only prone to cancer but other ailments too such as diabetes, heart disease, hypertension, cholesterol, cold, and flu to name but a few.

The presence of certain chemicals and substances also comprises cancer risk factors including cadmium, benzene, nickel, and asbestos found at various workplaces.

Employees exposed to such chemicals and substances in hazardous environments are at a greater risk of developing cancer.

Ozone therapy is a safer option among other natural cancer treatments. It works by killing off cancer cells which are anaerobic (thrive in absence of oxygen) in nature, and cannot survive in the presence of pure oxygen.

All in all, joining support groups, talking to family and friends, social interaction, along with appropriate exercise can together play a vital role in alleviation, prevention, and treatment of this dreadful disease.

Comments are closed.

Special Procedures

Click on Any Topic

Bone Marrow Transplants

Organ Transplants

Stem Cells



Physician Assisted Suicide

Medical Topics
  • Long-Term Data Back Anti-PD-1 in Advanced Non-Squamous NSCLC
    (MedPage Today) -- Long-term data from an early first-line trial of pembrolizumab (Keytruda) plus chemotherapy showed that more than half of patients with advanced non-squamous non-small cell lung cancer (NSCLC) remained alive at 3 years. In cohort...
  • Suze Orman's Schwannoma
    (MedPage Today) -- Financial advisor, author and former CNBC host Suze Orman has always stressed that it is a mistake for people to ignore their money problems. Now she wants you to know that "the most vital and stupid mistake I could ever make...
  • 'License' to Smoke After Negative Lung Screening?
    (MedPage Today) -- Some individuals appear to interpret a negative low-dose CT (LDCT) lung screening scan as a green light to resume smoking, a post hoc analysis of the National Lung Screening Trial (NLST) found. For example, highly nicotine dependent...
  • Hunting Resistance Mechanisms in RET-Fusion Lung Cancer
    (MedPage Today) -- As detected by circulating tumor DNA (ctDNA), acquired resistance to pralsetinib (Gavreto) in RET fusion-positive lung cancer was relatively uncommon, findings from the ARROW study suggested. In 42 non-small cell lung cancer...
  • Dual Checkpoint Blockade With Some Chemo Boosts OS in NSCLC
    (MedPage Today) -- A first-line immune checkpoint inhibitor combination of nivolumab (Opdivo) plus ipilimumab (Yervoy) improved survival in patients with advanced non-small cell lung cancer (NSCLC) when added to a limited course of chemotherapy...
Content Protected Using Blog Protector By: PcDrome.